Final SVR24 Data From the Phase 3 C-Edge Treatment-Naïve Study of Elbasvir (EBR)/Grazoprevir (GZR) in Patients with Chronic HCV Genotype 1, 4 or 6 Infection

Stefan Zeuzem, Eléonora De Martin, K.R. Reddy et al.|Journal of Hepatology|2016

Cited by 1